The long-term outcomes and histological transformation in class II lupus nephritis

References

1. ↵
   1. Teh CL,
   2. Phui VE,
   3. Ling GR,
   4. Ngu LS,
   5. Wan SA,
   6. Tan CH

   (2018) Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience. Clin Kidney J 11:56–61.

   OpenUrl
2. ↵
   1. Hanly JG,
   2. O'Keeffe AG,
   3. Su L,
   4. Urowitz MB,
   5. Romero-Diaz J,
   6. Gordon C,
   7. et al.

   (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55:252–262.

   OpenUrlCrossRefPubMed
3. ↵
   1. Dall'Era M,
   2. Cisternas MG,
   3. Smilek DE,
   4. Straub L,
   5. Houssiau FA,
   6. Cervera R,
   7. et al.

   (2015) Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis Cohort. Arthritis Rheumatol 67:1305–1313.

   OpenUrl
4. ↵
   1. Wilhelmus S,
   2. Bajema IM,
   3. Bertsias GK,
   4. Boumpas DT,
   5. Gordon C,
   6. Lightstone L,
   7. et al.

   (2016) Lupus nephritis management guidelines compared. Nephrol Dial Transplant 31:904–913.

   OpenUrlCrossRefPubMed
5. 1. Tunnicliffe DJ,
   2. Singh-Grewal D,
   3. Kim S,
   4. Craig JC,
   5. Tong A

   (2015) Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines. Arthritis Care Res (Hoboken) 67:1440–1452.

   OpenUrl
6. ↵
   1. Muangchan C,
   2. van Vollenhoven RF,
   3. Bernatsky SR,
   4. Smith CD,
   5. Hudson M,
   6. Inanç M,
   7. et al.

   (2015) Treatment Algorithms in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 67:1237–1245.

   OpenUrl
7. ↵
   1. Bajema IM,
   2. Wilhelmus S,
   3. Alpers CE,
   4. Bruijn JA,
   5. Colvin RB,
   6. Cook HT,
   7. et al.

   (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796.

   OpenUrlCrossRefPubMed
8. ↵
   1. Pakozdi A,
   2. Pyne D,
   3. Sheaff M,
   4. Rajakariar R

   (2018) Utility of a repeat renal biopsy in lupus nephritis: a single centre experience. Nephrol Dial Transplant 33:507–513.

   OpenUrl
9. 1. Narváez J,
   2. Ricse M,
   3. Gomà M,
   4. Mitjavila F,
   5. Fulladosa X,
   6. Capdevila O,
   7. et al.

   (2017) The value of repeat biopsy in lupus nephritis flares. Medicine (Baltimore) 96:e7099.

   OpenUrlPubMed
10. ↵
    1. Tannor EK,
    2. Bates WD,
    3. Moosa MR

    (2018) The clinical relevance of repeat renal biopsies in the management of lupus nephritis: a South African experience. Lupus 27:525–535.

    OpenUrl
11. ↵
    1. Collado MV,
    2. Dorado E,
    3. Rausch S,
    4. Gomez G,
    5. Khoury M,
    6. Zazzetti F,
    7. et al.

    (2016) Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis. J Clin Rheumatol 22:299–306.

    OpenUrl
12. ↵
    1. Castrejón I,
    2. Tani C,
    3. Jolly M,
    4. Huang A,
    5. Mosca M

    (2014) Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol 32(5 Suppl 85):S85–S95.

    OpenUrl
13. ↵
    1. Subspecialty Group of Renal Diseases, the Society of Pediatrics, Chinese Medical Association

    (2018) Evidence-based guideline on diagnosis and treatment of lupus nephritis (2016). Zhonghua Er Ke Za Zhi 56:88–94.

    OpenUrl
14. ↵
    1. Tang Y,
    2. Zhang W,
    3. Zhu M,
    4. Zheng L,
    5. Xie L,
    6. Yao Z,
    7. et al.

    (2018) Lupus nephritis pathology prediction with clinical indices. Sci Rep 8:10231.

    OpenUrl
15. ↵
    1. The clinical significance of serial kidney biopsies in lupus nephritis

    (2014) Abdulkareem O Alsuwaida. Mod Rheumatol 24:453–456.

    OpenUrl